The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study

MLA

Xiuwen Wang, et al. “The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study.” Frontiers in Oncology, vol. 10, Nov. 2020. EBSCOhost, https://doi.org/10.3389/fonc.2020.594125.

APA

Xiuwen Wang, Jun Wang, Alei Feng, Xiangling Wang, Jintao Liu, Ling Peng, Jinbo Yue, Jisheng Li, Lei Cong, & Li Li. (2020). The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.594125

Chicago

Xiuwen Wang, Jun Wang, Alei Feng, Xiangling Wang, Jintao Liu, Ling Peng, Jinbo Yue, Jisheng Li, Lei Cong, and Li Li. 2020. “The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study.” Frontiers in Oncology 10 (November). doi:10.3389/fonc.2020.594125.